Key facts
- It has raised $79.1M; the latest was Early Stage VC ($9.3M) in Sep 2025.
- Notable investors include Johnson & Johnson JJDC, Guolian Investment, Granite Asia, INCE Capital, NRL Capital — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Ronovo Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Ronovo Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ronovo Surgical
Developer of a soft tissue surgery robot platform designed to perform minimally invasive surgery. The company's platform leverages next-generation robotics and advanced digital solutions to address surgical specialties across the spectrum, optimizing patient outcomes and health economics and disrupting surgical care in China, enabling medical industry users to improve surgery efficiency and precision.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2019
- Website
- ronovo.com/
- Ownership
- Privately Held (backing)
Ronovo Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ronovo Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ronovo Surgical in its N-PORT filings yet. We sweep new filings monthly.